| Typicality: | 0.437 |
| Saliency: | 0.438 |
| in this process | 7 | location |
| in the development of pharmacogenetic guidelines | 5 | transitive-object |
| in quality control | 5 | location |
| department → have → leading role | 12 |
| department → take → lead role | 9 |
| department → take → leading role | 8 |
| department → taken → leading role | 3 |
| negative | neutral | positive |
| 0.028 | 0.536 | 0.437 |
| Raw frequency | 32 |
| Normalized frequency | 0.438 |
| Modifier score | 0.500 |
| Perplexity | 97.475 |